Keyphrases
Randomized Placebo-controlled Trial
100%
Obese Adults
100%
Histaminergic
100%
Betahistine
100%
Massive Weight Loss
50%
Placebo Groups
50%
Morbid Obesity
50%
Headache
25%
Adverse Events
25%
Strong Predictor
25%
Weight Loss
25%
Histamine
25%
Treatment Group
25%
Treatment Duration
25%
Non-Hispanic
25%
Healthy Participants
25%
Subgroup Analysis
25%
Dose-ranging
25%
Adverse Effect Profile
25%
Weight Loss Measurements
25%
Weight Loss Predictors
25%
Measurement Weights
25%
Histamine H3
25%
Medicine and Dentistry
Placebo
100%
Betahistine
100%
Adverse Event
50%
Histamine
50%
Headache
25%
Subgroup Analysis
25%
Comorbidity
25%
Pharmacology, Toxicology and Pharmaceutical Science
Placebo
100%
Betahistine
100%
Adverse Event
50%
Histamine
50%
Headache
25%
Comorbidity
25%
Biochemistry, Genetics and Molecular Biology
Histaminergic
100%
Histamine
100%
Agonist
50%
Comorbidity
50%
Immunology and Microbiology
Histamine
100%
Agonist
50%
Comorbidity
50%